000			02098 a2200625 4500
005			20250516104924.0
264		0	_c20130110
008			201301s 0 0 eng d
022			_a1528-0020
024	7		_a10.1182/blood-2012-05-431825 _2doi
040			_aNLM _beng _cNLM
100	1		_aGhesquières, Hervé
245	0	0	_aClinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. _h[electronic resource]
260			_bBlood _cSep 2012
300			_a2650-7 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aInternational Agencies
650	0	4	_aLymphoma, Follicular _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolymorphism, Single Nucleotide _xgenetics
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aReceptors, IgG _xgenetics
650	0	4	_aRemission Induction
650	0	4	_aRituximab
650	0	4	_aSurvival Rate
700	1		_aCartron, Guillaume
700	1		_aSeymour, John Francis
700	1		_aDelfau-Larue, Marie-Hélène
700	1		_aOffner, Fritz
700	1		_aSoubeyran, Pierre
700	1		_aPerrot, Aurore
700	1		_aBrice, Pauline
700	1		_aBouabdallah, Réda
700	1		_aSonet, Anne
700	1		_aDupuis, Jehan
700	1		_aCasasnovas, Olivier
700	1		_aCatalano, John Vincent
700	1		_aDelmer, Alain
700	1		_aJardin, Fabrice
700	1		_aVerney, Aurélie
700	1		_aDartigues, Peggy
700	1		_aSalles, Gilles
773	0		_tBlood _gvol. 120 _gno. 13 _gp. 2650-7
856	4	0	_uhttps://doi.org/10.1182/blood-2012-05-431825 _zAvailable from publisher's website
999			_c22018025 _d22018025